Don't miss an issue! Renew/subscribe for FREE today.
×

Straumann Chooses JUVORA™ Dental Disc to Extend Its Digital Restoration Treatment Options

Posted on Wednesday, May 23, 2018

JUVORA™ solutions are to become available to more dentists and their patients worldwide: Straumann has added the JUVORA dental disc to its portfolio. The company will provide milled JUVORA frameworks and also distribute the dental disc as part of the Straumann CARES® digital solutions system. It is suitable for fixed and removable prosthetics, such as implant dentures, full and partial dentures and overdentures, crowns, and bridges.

Straumann CARES digital solutions are facilitating dentistry's migration to digital-design techniques and workflows. The move to combining this with high-performance polymers is providing new digital production and treatment options for dentists and patients. Interest in the use of these materials for restorative dentistry is growing, as indicated in over 70 peer-reviewed publications over the last two years, as well as an increasing number of clinical studies and patient surveys. 

Strong clinical data, real-world patient experience, and backing from leaders within the dental profession are expected to support increasing use of this innovative product. In addition, the service provided by Juvora Limited includes regulatory clearance/certification and a JUVORA training guide. The training guide is available as an app via app stores and includes training and product information to support dental labs and dentists.

JUVORA prosthetics are made entirely of implantable PEEK-OPTIMA™ polymer from Invibio Biomaterial Solutions. This innovative material flexes and, unlike metal, enables the absorption of shock in the masticatory system, protecting the device and patient, especially in cases of bruxism which can lead to parafunction.1 In addition, it offers the potential for the CAD/CAM milling of JUVORA-based solutions up to three times faster than an equivalent titanium product.2 JUVORA prosthetics seek to improve the quality of life for patients, as well as clinical outcomes for dentists3, and offer manufacturing efficiency2 as an added benefit. In a patient survey over 20 months, 99% of patients rated JUVORA highly for comfort.4

John Devine, Medical Business Director at Invibio Biomaterial Solutions, comments, “For many years, Straumann has led innovation in dentistry and dental biomaterials. Working together with them as one of the industry's leaders will further pave the way to digital dentistry and allow patients across the globe to access customized high quality prosthetic dental implants based on our PEEK biomaterials.”

Since PEEK-OPTIMA Natural was launched as the world’s first implantable PEEK polymer more than 15 years ago, Invibio and Juvora have pioneered the use of high-performance polymers in long-term implantable medical-device applications such as spine, arthroscopy, trauma, and dental. In the process, evidence of the clinical benefits of JUVORA has been amassed as a framework material in implant and tooth-borne prosthetics. European CE mark certification for JUVORA was secured in 2012, followed by initial US FDA approval in 2014, and a further FDA approval in 2017 for JUVORA in implant-borne restorations. In 2017, JUVORA was also granted a US patent.

 

(1) M Rosentritt, S. Schneider-Feyrer, M. Behr, V. Preis (2017). in Vitro Shock Absorption Tests on Implant-Supported Crowns: Influence of Crown Materials and Luting Agents. The International Journal of Oral & Maxillofacial Implants, 2017 May 18. doi: 10.11607/jomi.5463.

(2) Invibio data on file. Independent laboratory test indicated milling JUVORA implant prosthetic framework in one hour, 21 minutes, versus Titanium equivalent in three hours, 50 minutes.

(3) Siewert, B. (2017), PEEK in Dental Prosthetics. Industry Symposium. EAO Conference. Madrid, Spain. 5th October 2017. Available to watch at https://www.youtube.com/watch?v=wNvSwG4CaeYB.

(4) Invibio data on file. JUVORA prosthetics patient survey from 92 cases, July 2013-March 2015. 







Recent Headlines

© 2024 BroadcastMed LLC | Privacy Policy